5IPA
Structure of Transcriptional Regulatory Repressor Protein - EthR from Mycobacterium Tuberculosis in complex with (E)-3-(furan-3-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one at 1.78A resolution
Summary for 5IPA
Entry DOI | 10.2210/pdb5ipa/pdb |
Descriptor | TetR-family transcriptional regulatory repressor protein, (2E)-3-(furan-3-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one (3 entities in total) |
Functional Keywords | ethr, transcription, represor, boosting effect |
Biological source | Mycobacterium tuberculosis (strain ATCC 25177 / H37Ra) |
Total number of polymer chains | 1 |
Total formula weight | 24355.38 |
Authors | Blaszczyk, M.,Surade, S.,Nikiforov, P.O.,Abell, C.,Blundell, T.L. (deposition date: 2016-03-09, release date: 2017-03-29, Last modification date: 2024-01-10) |
Primary citation | Nikiforov, P.O.,Blaszczyk, M.,Surade, S.,Boshoff, H.I.,Sajid, A.,Delorme, V.,Deboosere, N.,Brodin, P.,Baulard, A.R.,Barry, C.E.,Blundell, T.L.,Abell, C. Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays. ACS Chem. Biol., 12:1390-1396, 2017 Cited by PubMed Abstract: Small-molecule inhibitors of the mycobacterial transcriptional repressor EthR have previously been shown to act as boosters of the second-line antituberculosis drug ethionamide. Fragment-based drug discovery approaches have been used in the past to make highly potent EthR inhibitors with ethionamide boosting activity both in vitro and ex vivo. Herein, we report the development of fragment-sized EthR ligands with nanomolar minimum effective concentration values for boosting the ethionamide activity in Mycobacterium tuberculosis whole-cell assays. PubMed: 28314097DOI: 10.1021/acschembio.7b00091 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.78 Å) |
Structure validation
Download full validation report